Back HCV Treatment

Predictors of Sustained Treatment Response in HIV-HCV Coinfected Patients Receiving Routine Care

As reported at the recent Digestive Disease Week annual meeting (DDW 2009) in Chicago, Lisa Backus and colleagues evaluated the predictors of sustained virological response (SVR) for HIV-HCV coinfected patients receiving pegylated interferon plus ribavirin in routine care at Veterans Affairs (VA) medical facilities.

Read more: